Showing results (1201-1210 of 1,351) with videos related to

Sort By:
Pageof 136
European Journal of Cancer (Oxford, England : 1990)|May 27, 2022
European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022Claus Garbe, Teresa Amaral, Ketty Peris, et al.
European Journal of Cancer (Oxford, England : 1990)|April 10, 2021
Combining CNN-based histologic whole slide image analysis and patient data to improve skin cancer classificationJulia Höhn, Eva Krieghoff-Henning, Tanja B Jutzi, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2020
European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and preventionAlexander J Stratigos, Claus Garbe, Clio Dessinioti, et al.
JAMA Dermatology|February 7, 2024
Federated Learning for Decentralized Artificial Intelligence in Melanoma DiagnosticsSarah Haggenmüller, Max Schmitt, Eva Krieghoff-Henning, et al.
Molecular Psychiatry|January 4, 2024
A primer on the use of machine learning to distil knowledge from data in biological psychiatryThomas P Quinn, Jonathan L Hess, Victoria S Marshe, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 7, 2024
European consensus-based interdisciplinary guideline for diagnosis, treatment and prevention of actinic keratoses, epithelial UV-induced dysplasia and field cancerization on behalf of European Association of Dermato-Oncology, European Dermatology Forum, European Academy of Dermatology and Venereology and Union of Medical Specialists (Union Européenne des Médecins Spécialistes)Lidija Kandolf, Ketty Peris, Josep Malvehy, et al.
European Journal of Cancer (Oxford, England : 1990)|August 21, 2023
European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023Ketty Peris, Maria Concetta Fargnoli, Roland Kaufmann, et al.
British Journal of Cancer|October 22, 2020
Melanoma recurrence patterns and management after adjuvant targeted therapy: a multicentre analysisPrachi Bhave, Lalit Pallan, Georgina V Long, et al.
The New England Journal of Medicine|September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 studyG V Long, K T Flaherty, D Stroyakovskiy, et al.
Pageof 136